University of Tennessee Health Science Center / Yuefeng Wang*
Abstract
Definitive pelvic chemoradiation is the standard of care for locally advanced cervical cancer.1 However, the role of definitive local radiation therapy for metastatic cervical cancer has not been established. In addition, there is growing evidence that local therapies may be associated with an increase in survival among patients with some types of metastatic cancers.2-5 In this study, we evaluated overall survival among patients with metastatic cervical cancer treated with chemotherapy alone vs pelvic chemoradiation.
“This article has a delayed release (embargo) and will be available in PMC on July 26, 2019.”
Author information
Wang Y1, Farmer M1, Izaguirre EW1, Schwartz DL1, Somer B2, Tillmanns T3, Ballo MT1.
1
Department of Radiation Oncology, West Cancer Center, University of Tennessee Health Science Center, Memphis.
2
Department of Hematology/Oncology, West Cancer Center, University of Tennessee Health Science Center, Memphis.
3
Department of Gynecologic Oncology, West Cancer Center, University of Tennessee Health Science Center, Memphis.